Table 4.
Adverse events in the treatment group
| Adverse events | n(%) | Corresponding treating measures |
|---|---|---|
| Intracranial infection | – | No complications |
| Cerebrospinal fluid leakage | – | No complications |
| Tumorigenesis | – | No complications |
| Neurologic deterioration | – | No complications |
| Constipation | 6(30) | Symptomatic treatment |
| Urinary system infection | 5(25) | Antibiotic injection |
| Pulmonary infection | 4(20) | Antibiotic injection |
| Psychological disorder | 4(20) | Psychological intervention |
| Osteoporosis | 3(15) | Medication therapy (alendronate sodium, calcium) |
| Pressure sores | 2(10) | Strengthening nursing, dressing change daily |
| Deep venous thrombosis | 1(5) | Anticoagulation and thrombolysis therapy |